DataVXAdvanced MaterialsPaper
journal article·2020-01

Fast‐Acting Black‐Phosphorus‐Assisted Depression Therapy with Low Toxicity

Liguo Jin, Ping Hu, Yinyin Wang, Luojia Wu, Kang Qin, Haoxin Cheng, Shuhua Wang, Bingxing Pan, Hongbo Xin, Wenhua Zhang, Xiaolei Wang

Advanced Materials· Volume 32· Issue 2
Publisher page
Source abstract

Abstract

Abstract A black phosphorus (BP)‐nanosheet‐based drug‐delivery system containing a therapeutic drug (Fluoxetine, Flu) is synthesized. According to subsequent behavioral, biochemical, and electrophysiological analysis, BP‐Flu, after irradiated with near‐infrared light (808 nm), can significantly reduce the therapy time of depression. Meanwhile, the inherent biotoxicity of Flu is also alleviated.
Source: crossref · Quality: baseline

Research context

Nanomaterials

OpenAlex topics: 2D Materials and Applications · Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry Nanchang University Nanchang Jiangxi 330088 China

The National Engineering Research Center for Bioengineering Drugs and the Technologies Institute of Translational Medicine Nanchang University Nanchang Jiangxi 330088 China

The Center for Biotechnology and Biopharmaceutics Institute of Translational Medicine Nanchang University Nanchang 330031 China

Laboratory of Fear and Anxiety Disorders Institute of Life Science Nanchang University, Nanchang Nanchang 330031 China

Funding

National Natural Science Foundation of China · Education Department of Jiangxi Province · Natural Science Foundation of Jiangxi Province

References (29)

Show source-provided references
1. Friedrich M. J. · JAMA, J. Am. Med. Assoc. · 2017 · 317 · 1517
2. 10.1038/s41563-018-0230-210.1038/s41563-018-0230-2 ↗
3. 10.1038/nmat429910.1038/nmat4299 ↗
4. 10.1016/j.nantod.2019.02.01210.1016/j.nantod.2019.02.012 ↗
5. 10.1039/C8TB00729B10.1039/C8TB00729B ↗
6. 10.1002/adfm.20170583310.1002/adfm.201705833 ↗
7. 10.1002/adfm.20180830610.1002/adfm.201808306 ↗
8. 10.1039/C8CS00342D10.1039/C8CS00342D ↗
9. 10.1073/pnas.171442111510.1073/pnas.1714421115 ↗
10. 10.1039/C8CC00931G10.1039/C8CC00931G ↗
11. 10.1038/ncomms547510.1038/ncomms5475 ↗
12. 10.1038/nnano.2015.7110.1038/nnano.2015.71 ↗
13. 10.1002/anie.20150615410.1002/anie.201506154 ↗
14. 10.1021/jacs.5b0602510.1021/jacs.5b06025 ↗
15. 10.1016/j.biomaterials.2016.03.02210.1016/j.biomaterials.2016.03.022 ↗
16. 10.1002/adma.20170345810.1002/adma.201703458 ↗
17. 10.1002/adma.20160386410.1002/adma.201603864 ↗
18. Mun A. R. · Anticancer Res. · 2013 · 33 · 3691
19. 10.1139/apnm-2014-046210.1139/apnm-2014-0462 ↗
20. 10.1021/nn506408v10.1021/nn506408v ↗
21. 10.1038/nm.316210.1038/nm.3162 ↗
22. 10.1016/j.conb.2011.04.00310.1016/j.conb.2011.04.003 ↗
23. 10.1038/npp.2015.8510.1038/npp.2015.85 ↗
24. 10.1155/2017/726013010.1155/2017/7260130 ↗
25. Koo J. W. · Biol. Psychiatry · 2019 · 19
26. 10.3109/15622975.2014.88565910.3109/15622975.2014.885659 ↗
27. 10.1016/S2215-0366(15)00579-910.1016/S2215-0366(15)00579-9 ↗
28. 10.1016/j.biopsych.2018.06.01910.1016/j.biopsych.2018.06.019 ↗
29. 10.1016/j.biopsych.2018.12.01010.1016/j.biopsych.2018.12.010 ↗